New EU MedTech Regulatory Reform for Medical Technologies

MedTech Europe advocates for essential reforms to the EU regulatory framework for medical technologies to facilitate quicker access to safe, innovative solutions while enhancing industry competitiveness. The current system is described as slow, costly, and excessively complex, hindering innovation and patient access.
To address these issues, MedTech Europe asserts that legislative reform discussions should commence immediately, alongside the implementation of four targeted measures.

The four proposed measures on the are:

• Streamline Product Approvals: The existing conformity assessment process is unpredictable, expensive, and time-consuming, particularly for SMEs. Establishing clear timelines, improving transparency regarding the time and costs involved per device type, enhancing efficiency in the approval process, and facilitating structured dialogue between companies and Notified Bodies can expedite the approval process, making it faster, more efficient, and less costly.
• Simplify Change Notifications: Notified Bodies frequently require notification for minor changes, causing backlogs and delays. By categorizing changes based on complexity and focusing only on significant modifications (e.g., those affecting safety or performance), the process can be streamlined, reducing unnecessary delays and ensuring patients have access to updated devices.
• Accelerate Breakthrough Innovations: Unlike other regions such as the US and Japan, Europe lacks a fast-track pathway for breakthrough medical technologies. Establishing a dedicated pathway with a maximum 120-day review timeline, clear eligibility criteria, and conditional approval models would enable quicker access to life-saving innovations while maintaining high safety standards.
• Adopt Risk-Based Certification: The current five-year certificate renewal process duplicates oversight efforts and creates bottlenecks. Transitioning to a lifetime risk-based certification model would eliminate unnecessary re-certifications, allowing resources to focus on safety concerns or significant changes, thereby supporting innovation and reducing administrative burdens.

EU MedTech Regulatory Reform Considerations

MedTech Europe considers these measures crucial to maintaining Europe’s status as a global leader in medical technologies, ensuring patients can access advanced treatments promptly and fostering a sustainable, innovation-friendly healthcare ecosystem.

To learn more about the new EU MedTech regulatory reform changes, click here.

For further information, contact us.

____________________________________________

Learn How MedEnvoy Can Assist you:

• EU Authorized Representative
• EU Regulatory Importer